$SWAG
Stran & Company, Inc. Stock $swag

$swag Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023039798 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$17.47M	$15.78M	$12.26M
YoY Change	17.99%	28.69%	62.5%
Cost Of Revenue	$12.39M	$11.08M	$9.041M
YoY Change	12.19%	22.57%	72.14%
Gross Profit	$5.077M	$4.694M	$3.218M
YoY Change	35.02%	45.86%	40.43%
Gross Profit Margin	29.06%	29.75%	26.25%
Selling, General & Admin	$16.53M	$18.03M	$4.024M
YoY Change	290.56%	347.96%	52.12%
% of Gross Profit	325.57%	384.05%	125.05%
Research & Development	$1.163M	$963.0K
YoY Change
% of Gross Profit	22.91%	20.52%
Depreciation & Amortization	$235.0K	$259.4K	$144.3K
YoY Change	42.23%	79.84%	70.81%
% of Gross Profit	4.63%	5.53%	4.48%
Operating Expenses	$6.351M	$6.079M	$4.024M
YoY Change	50.07%	51.06%	52.12%
Operating Profit	-$1.274M	-$1.385M	-$806.1K
YoY Change	169.98%	71.84%	127.86%
Interest Expense	-$1.163M	$2.620M	-$3.730K
YoY Change	-48337.25%	-70341.29%	-71.0%
% of Operating Profit
Other Income/Expense, Net	$128.0K	$326.6K	$86.92K
YoY Change	438.1%	275.75%
Pretax Income	-$1.146M	-$1.059M	-$722.9K
YoY Change	134.1%	46.44%	97.18%
Income Tax	-$308.0K	-$364.0K	-$177.1K
% Of Pretax Income
Net Earnings	-$838.3K	-$694.5K	-$545.8K
YoY Change	87.36%	27.25%	88.16%
Net Earnings / Revenue	-4.8%	-4.4%	-4.45%
Basic Earnings Per Share	-$0.05	-$0.04	-$0.03
Diluted Earnings Per Share	-$0.05	-$0.04	-$27.21K
COMMON SHARES
Basic Shares Outstanding	18.42M shares	18.32M shares	20.06M shares
Diluted Shares Outstanding	18.54M shares	18.48M shares	20.06M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.143M	$617.0K	$40.00M
YoY Change	-88.86%	-98.46%	7681.53%
Cash & Equivalents	$15.27M	$10.60M	$40.00M
Short-Term Investments	$10.28M	$10.27M
Other Short-Term Assets	$1.977M	$3.810M	$1.710M
YoY Change	40.03%	122.83%	306.51%
Inventory	$5.821M	$5.666M	$6.147M
Prepaid Expenses
Receivables	$13.96M	$11.91M	$9.845M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$49.63M	$41.52M	$57.71M
YoY Change	5.8%	-28.05%	619.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.295M	$1.193M	$1.670M
YoY Change	85.78%	-28.52%	-9.48%
Goodwill
YoY Change
Intangibles	$10.71M	$5.655M
YoY Change	169.16%
Long-Term Investments	$6.466M	$6.759M	$231.5M
YoY Change	-97.21%	-97.08%
Other Assets	$972.0K	$1.065M	$91.67K
YoY Change	4140.84%	1061.78%	65.26%
Total Long-Term Assets	$13.48M	$7.624M	$5.783M
YoY Change	139.83%	31.83%	41.8%
TOTAL ASSETS
Total Short-Term Assets	$49.63M	$41.52M	$57.71M
Total Long-Term Assets	$13.48M	$7.624M	$5.783M
Total Assets	$63.11M	$49.15M	$63.49M
YoY Change	20.14%	-22.59%	424.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.94M	$18.46M	$4.003M
YoY Change	679.25%	361.11%	45.48%
Accrued Expenses	$11.56M	$10.54M	$1.026M
YoY Change	951.73%	927.38%	-25.56%
Deferred Revenue
YoY Change
Short-Term Debt	$3.155M	$7.729M	$162.4K
YoY Change	1843.21%	4660.41%	-91.04%
Long-Term Debt Due	$3.190M	$2.170M	$1.573M
YoY Change	99.54%	37.96%	164.72%
Total Short-Term Liabilities	$19.49M	$8.399M	$18.70M
YoY Change	86.25%	-55.1%	161.22%
LONG-TERM LIABILITIES
Long-Term Debt	$59.46M	$56.26M	$1.489M
YoY Change	4691.35%	3679.39%	-42.29%
Other Long-Term Liabilities	$37.11M	$32.62M	$704.6K
YoY Change	5854.59%	4528.74%	-30.88%
Total Long-Term Liabilities	$5.646M	$2.050M	$2.193M
YoY Change	202.87%	-6.51%	-39.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.49M	$8.399M	$18.70M
Total Long-Term Liabilities	$5.646M	$2.050M	$2.193M
Total Liabilities	$25.14M	$10.45M	$20.90M
YoY Change	103.88%	-50.0%	94.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$449.3K	$389.0K
YoY Change	-151.72%
Common Stock	$1.855K	$1.849K
YoY Change	-3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.97M	$38.70M	$42.59M
YoY Change
Total Liabilities & Shareholders Equity	$63.11M	$49.15M	$63.49M
YoY Change	20.14%	-22.59%	424.84%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$838.3K	-$694.5K	-$545.8K
YoY Change	87.36%	27.25%	88.16%
Depreciation, Depletion And Amortization	$235.0K	$259.4K	$144.3K
YoY Change	42.23%	79.84%	70.81%
Cash From Operating Activities	-$7.969M	-$3.592M	$7.099M
YoY Change	-17.91%	-150.61%	18257.23%
INVESTING ACTIVITIES
Capital Expenditures	$592.0K	$21.00K	-$627.9K
YoY Change	-680.85%	-103.34%	410.16%
Acquisitions
YoY Change
Other Investing Activities	$1.000K	$3.000K
YoY Change
Cash From Investing Activities	-$591.0K	-$680.8K	-$627.9K
YoY Change	479.87%	8.43%	410.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.09M	-$383.9K	1.307M
YoY Change	-656.08%	-129.36%	-2783.42%
NET CHANGE
Cash From Operating Activities	-7.969M	-$3.592M	7.099M
Cash From Investing Activities	-591.0K	-$680.8K	-627.9K
Cash From Financing Activities	11.09M	-$383.9K	1.307M
Net Change In Cash	2.526M	-$4.657M	7.778M
YoY Change	-121.4%	-159.87%	-5942.55%
FREE CASH FLOW
Cash From Operating Activities	-$7.969M	-$3.592M	$7.099M
Capital Expenditures	$592.0K	$21.00K	-$627.9K
Free Cash Flow	-$8.561M	-$3.613M	$7.727M
YoY Change	-10.87%	-146.77%	4676.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41038
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3297200
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Heritage Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02171
CY2023Q1	dei	City Area Code CityAreaCode	800
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	833-3309
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18420264	shares
CY2023Q1	us-gaap	Cash Cash	10596595	usd
CY2022Q4	us-gaap	Cash Cash	15253756	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	10269101	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9779355	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11914586	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14442626	usd
CY2023Q1	strn	Deferred Income Taxes DeferredIncomeTaxes	1205000	usd
CY2022Q4	strn	Deferred Income Taxes DeferredIncomeTaxes	841000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5665924	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	611320	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	386884	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	1172754	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	910486	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	41522739	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48569130	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1193356	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5654804	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6272205	usd
CY2023Q1	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	775742	usd
CY2022Q4	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	784683	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	6430546	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7056888	usd
CY2023Q1	us-gaap	Assets Assets	49146641	usd
CY2022Q4	us-gaap	Assets Assets	56626108	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	2171603	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1809874	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	320197	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	324594	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2938995	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	674123	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	608589	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1871846	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	259633	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	365303	usd
CY2023Q1	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2022Q4	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8398755	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13955523	usd
CY2023Q1	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	1594944	usd
CY2022Q4	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	2845944	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	455545	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	460089	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2050489	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3306033	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18483334	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18483334	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18475521	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18475521	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1849	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1848	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38306533	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38279151	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	389015	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1083553	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	38697397	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49146641	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56626108	usd
CY2023Q1	us-gaap	Revenues Revenues	15776247	usd
CY2022Q1	us-gaap	Revenues Revenues	12259583	usd
CY2023Q1	strn	Purchases Expenses PurchasesExpenses	10023546	usd
CY2022Q1	strn	Purchases Expenses PurchasesExpenses	7956616	usd
CY2023Q1	strn	Freight Expenses FreightExpenses	1058748	usd
CY2022Q1	strn	Freight Expenses FreightExpenses	1084802	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11082294	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9041418	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4693953	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3218165	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6079095	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4024218	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6079095	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4024218	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1385142	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-806053	usd
CY2023Q1	us-gaap	Other Income OtherIncome	56637	usd
CY2022Q1	us-gaap	Other Income OtherIncome	-3680	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	138082	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	90595	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	131885	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-3731	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	326604	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83184	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1058538	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-722869	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-364000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-177055	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-694538	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18477604	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20061143	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18477604	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20061143	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1307362	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	118692	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	42591859	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27383	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-694538	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	38697397	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-694538	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-364000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-174400	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	259412	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	144253	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-55687	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	64	usd
CY2022Q1	strn	Reduction In Contingent Earn Out Liability ReductionInContingentEarnOutLiability	-215360	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	27382	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	118692	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	93884	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2528040	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	861952	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1201640	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	916666	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	224436	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-126100	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-262268	usd
CY2022Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-538244	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1112662	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-980731	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	65534	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-125895	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1238698	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1064773	usd
CY2023Q1	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	-6000000	usd
CY2022Q1	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	10000000	usd
CY2023Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-105670	usd
CY2022Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	3924	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3592439	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7098744	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	540290	usd
CY2023Q1	strn	Additions To Property And Equipment AdditionsToPropertyAndEquipment	-284959	usd
CY2022Q1	strn	Additions To Property And Equipment AdditionsToPropertyAndEquipment	-87624	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	395862	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-680821	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-627914	usd
CY2023Q1	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	383901	usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1307362	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-383901	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1307362	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4657161	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7778192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15253756	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32226668	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10596595	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40004860	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3731	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	76073	usd
CY2022Q1	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition	1735000	usd
CY2023Q1	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	505370	usd
CY2022Q1	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	61887	usd
CY2023Q1	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-505370	usd
CY2022Q1	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-61887	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">8.</td><td style="text-align: justify">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">21.</td><td style="text-align: justify">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p>
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10373420	usd
CY2023Q1	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-104319	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	10269101	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	9958475	usd
CY2022Q4	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-179120	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9779355	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	223705	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	264160	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5642955	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6557040	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	22969	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	310524	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5665924	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	511677	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	501395	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1800053	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1525376	usd
CY2023Q1	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2379818	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2094859	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1186462	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1094769	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1193356	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.005	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.085	pure
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2023Q1	strn	Cost Of Sale Purchases CostOfSalePurchases	1989989	usd
CY2022Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	3571942	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	949006	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	479715	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2938995	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4051657	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2023Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2022	strn	Fair Market Value Payments FairMarketValuePayments	262500	usd
CY2023Q1	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	1871846	usd
CY2022	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	633148	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	633148	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	721608	usd
CY2023Q1	strn	Revenue Recognized RevenueRecognized	-15776247	usd
CY2022	strn	Revenue Recognized RevenueRecognized	-58953467	usd
CY2023Q1	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	17014945	usd
CY2022	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	58865007	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1871846	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	633148	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6000000	usd
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	104687	usd
CY2022Q1	us-gaap	Prepaid Rent PrepaidRent	105502	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	162358	usd
CY2023Q1	strn	Amount Accrues No Interest AmountAccruesNoInterest	162358	usd
CY2023Q1	strn	Right Of Use Assets RightOfUseAssets	775742	usd
CY2022Q4	strn	Right Of Use Assets RightOfUseAssets	784683	usd
CY2023Q1	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	320197	usd
CY2022Q4	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	324594	usd
CY2023Q1	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	455545	usd
CY2022Q4	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	460089	usd
CY2023Q1	strn	Operating Leases OperatingLeases	775742	usd
CY2022Q4	strn	Operating Leases OperatingLeases	784683	usd
CY2023Q1	strn	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	320197	usd
CY2023Q1	strn	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	322491	usd
CY2023Q1	strn	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	133054	usd
CY2023Q1	strn	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	775742	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.02	pure
CY2022Q1	strn	Warrant Exercised WarrantExercised	659456	shares
CY2023Q1	strn	Warrants Outstanding WarrantsOutstanding	4478134	shares
CY2022Q1	strn	Warrants Outstanding WarrantsOutstanding	4478134	shares
CY2021Q4	strn	Outstanding Voting Stock Percentage OutstandingVotingStockPercentage	0.654	pure
CY2022Q1	strn	Private Placement Exercise Price PrivatePlacementExercisePrice	1
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10345784	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.9
CY2022Q1	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P5Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	271589	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.81
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
CY2022Q1	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
CY2023Q1	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P4Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
CY2023Q1	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance	P4Y
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000000	usd
CY2023Q1	us-gaap	Shares Issued SharesIssued	1777657	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.87
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1777657	shares
CY2023Q1	strn	Stock Issued During Periods Value New Issue StockIssuedDuringPeriodsValueNewIssue	6667595	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27383	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	118692	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-years contractual terms.
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0358	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2924	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1587000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	3045700	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	61000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	6000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.15
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1642000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.06
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	75256	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1558000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.17
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	15000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9333	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.68
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1563667	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	525563	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.11
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.8
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.77
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1058538	usd
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	18477604	shares
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-722869	usd
CY2022Q1	us-gaap	Stock Dividends Shares StockDividendsShares	20061143	shares
CY2023Q1	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	-0.04
CY2022Q1	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	-0.03
CY2023Q1	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.04
CY2022Q1	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.03
CY2023Q1	strn	Warrants To Purchase WarrantsToPurchase	10074195	shares
CY2022Q1	strn	Warrants To Purchase WarrantsToPurchase	10074195	shares
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	525563	shares
CY2022Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	75256	shares
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-261000	usd
CY2022Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-131800	usd
CY2023Q1	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-261000	usd
CY2022Q1	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-131800	usd
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-103000	usd
CY2022Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-45255	usd
CY2023Q1	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-103000	usd
CY2022Q1	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-45255	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-364000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-177055	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4143000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2711000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	1205000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	287400	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	172325	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	45481	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Stran & Company, Inc.
CY2023Q1	strn	Reward Program Liability RewardProgramLiability		usd
CY2023Q1	strn	Reduction In Contingent Earn Out Liability ReductionInContingentEarnOutLiability		usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022Q1	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2023Q1	strn	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears		usd
CY2023Q1	strn	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears		usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1	strn	Weighted Average Life Years WeightedAverageLifeYears
CY2022Q1	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	strn	Weighted Average Life Years WeightedAverageLifeYears
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q1	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
CY2022Q1	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
CY2022Q1	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj		usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj		usd
CY2023Q1	strn	Warrants Warrants		shares
CY2022Q1	strn	Warrants Warrants		shares
CY2023Q1	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised		usd
CY2022Q1	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised		usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001872525

Files In Submission

Name	View Source	Status
strn-20230331_cal.xml	Edgar Link	unprocessable
0001213900-23-039798-index-headers.html	Edgar Link	pending
0001213900-23-039798-index.html	Edgar Link	pending
0001213900-23-039798.txt	Edgar Link	pending
0001213900-23-039798-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_stranandco.htm	Edgar Link	pending
f10q0323ex31-2_stranandco.htm	Edgar Link	pending
f10q0323ex32-1_stranandco.htm	Edgar Link	pending
f10q0323ex32-2_stranandco.htm	Edgar Link	pending
f10q0323_stranandco.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_stranandco_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strn-20230331.xsd	Edgar Link	pending
strn-20230331_def.xml	Edgar Link	unprocessable
strn-20230331_lab.xml	Edgar Link	unprocessable
strn-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWAG
Stran & Company, Inc. Stock $swag

2023 Q2 Form 10-Q Financial Statement

#000121390023039798 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG Stran & Company, Inc. Stock $swag

2023 Q2 Form 10-Q Financial Statement

#000121390023039798 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG
Stran & Company, Inc. Stock $swag